Piramal Phytocare (Delisted) share news and announcements
BSE: 532979
Formerly Piramal Life Sciences
Last traded ₹22.70 on 10 Dec 2019
Delisted on 27 May 2020.
Piramal Phytocare share news and announcements
488 announcements, routine notices left out, newest first. Page 8 of 10.
Nov 2012
Oct 2012
26 Oct · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2012. The results shall be subjected to limited review.
Aug 2012
6 Aug · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
May 2012
30 May · Legal
With reference to the "Increase in Price", Piramal Life Sciences Ltd has clarified to BSE that the Company is not aware of any information/announcement (including impending announcement) ....23 May · Change in Company Secretary
Ms.Vandana Chablani has ceased to be the Company Secretary of the Company with effect from May 19, 2012 and Mr. Ankit Sheth has been appointed as Company Secretary of the Company in her place.23 May · Change in Company Secretary
Ms. Vandana Chablani has ceased to be the Company Secretary of the Company with effect from May 19, 2012, and Mr. Ankit Sheth has been appointed ....21 May · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 26, 2012 to August 03, 2012 (both days inclusive) ....9 May · Board meeting
To inter-alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2012.
Apr 2012
28 Apr · Results
Company will declare / publish Audited Financial Results for the financial year ended March 31, 2012 within a period of sixty (60) days ....27 Apr · Results
Company will declare / publish Audited Financial Results for the financial year ended March 31, 2012 within a period of sixty (60) from the end of the financial year i.e. on or before May 30, 2012. Accordingly, the Company will not be declaring / publishing unaudited results for the last quarter ended March 31, 2012.
Feb 2012
Jan 2012
24 Jan · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the 3rd Quarter ended December 31,2011.9 Jan · Legal
Price movement : Significant price movement has been observed in Piramal Life Sciences Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Piramal Life Sciences Limited has vide its letter inter-alia stated, "We are not aware of any information/announcement (including impending announcement) which in our opinion may have a bearing on the price/volume behaviour in the scrip."9 Jan · Legal
With reference to Increase in Price, Piramal Life Sciences Ltd has clarified to informed BSE that the Company is not aware of any information / announcement (including impending announcement) ....
Dec 2011
Nov 2011
25 Nov · Business
Hon'ble Bombay High Court on November 25, 2011 has sanctioned the Scheme of Arrangement for Demerger of the NCE Research Unit of Piramal Life Sciences Limited into Piramal Healthcare Limited. Shareholders of Piramal Life Sciences Limited ('PLSL') to receive the equity shares of Piramal Healthcare Limited ('PHL') in the ratio of 1:4 (i.e. one share of Rs. 2 each of PHL for every 4 shares of Rs. 10/- each held in PLSL) under the aforesaid scheme.25 Nov · Business
Hon'ble Bombay High Court on November 25, 2011 has sanctioned the Scheme of Arrangement between Piramal Life Sciences Limited and Piramal ....
Oct 2011
21 Oct · Board meeting
Company had informed the Exchange that in view of paucity of time, it was decided that the results for the quarter ended September 30, 2011 be considered at a subsequent meeting for which necessary advance intimation would be given by the Company. The Company has now informed the Exchange that a meeting of the Board of Directors of the Company will now be held on November 02, 2011 to consider and take on record the Unaudited Financial Results of the Company for the 2nd Quarter and half year ended September 30, 2011.13 Oct · Board Meeting Adjourned
Piramal Life Sciences Limited had informed the Exchange that a meeting of the Board of Directors of the Company will be held on October 13, 2011 to consider and take on record the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2011. The Company has now informed the Exchange that the in view of paucity of time, it was decided that the results for the quarter ended September 30, 2011 be considered at a subsequent meeting for which necessary advance intimation would be given by the Company.5 Oct · Board meeting
To consider and take on record the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2011.
Aug 2011
17 Aug · Meeting
At the Annual General Meeting of the members of the Company held on August 09, 2011 have approved the following: (1) Prof. Goverdhan Mehta has been re-appointed as a Director of the Company. (2) Sir Ravinder Maini has been re-appointed as a Director of the Company. (3) The Audited Accounts for the year ended March 31, 2011 were adopted. (4) M/s. Price Waterhouse & Co., Chartered Accountants, Mumbai have been re-appointed as Auditors of the Company.17 Aug · Meeting
Members at the Annual General Meeting (AGM) of the Company held on August 09, 2011, inter alia, have transacted the following: - ....